Sign up to save your podcasts
Or
Share Moderna’s Rise, JCP’s Split
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Moderna’s Rise, JCP’s Split
Moderna shares pop 20% on encouraging test results. JC Penney’s plan to survive involves splitting into two separate public companies: one for retail, one as a REIT. Bill Barker analyzes those stories as we dip into the Fool Mailbag to discuss retail and diversification.
View all episodes
By The Motley Fool
4.7
16041,604 ratings
Moderna shares pop 20% on encouraging test results. JC Penney’s plan to survive involves splitting into two separate public companies: one for retail, one as a REIT. Bill Barker analyzes those stories as we dip into the Fool Mailbag to discuss retail and diversification.
More shows like MarketFoolery
View all
Motley Fool Hidden Gems Investing
3,228 Listeners
InvestTalk
1,498 Listeners
Motley Fool Answers
807 Listeners
Rule Breaker Investing
938 Listeners
Investing Insights
518 Listeners
Bloomberg Surveillance
1,173 Listeners
Masters in Business
2,175 Listeners
Industry Focus
825 Listeners
The Investing for Beginners Podcast - Your Path to Financial Freedom
1,416 Listeners
Wall Street Breakfast
1,044 Listeners
The Best One Yet
9,722 Listeners
Chit Chat Stocks
196 Listeners
Ready For Retirement
828 Listeners
The Canadian Investor
82 Listeners
Early Retirement - Financial Freedom (Investing, Tax Planning, Retirement Strategy, Personal Finance)
597 Listeners
The Morgan Housel Podcast
989 Listeners
Stock Market Today With IBD
53 Listeners